Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP [1]
      • PEP4LEP project
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Clinical, epidemiological, and laboratory prognostic factors in patients with leprosy reactions: A 10-year retrospective cohort study

Antunes DE, Santos DF, Lima MIS, et al. Frontiers Media SA. Frontiers in Medicine. 2022;
Download PDF
Publication

Small-fibre neuropathy in leprosy the role of in vivo confocal microscopy: A cross-sectional study.

Cajueiro M, Cavalcanti B, Cavalcanti C, et al. Indian journal of dermatology, venereology and leprology. 2022;
Download PDF
Publication

Global prevalence of resistance to rifampicin in Mycobacterium leprae: A meta-analysis

Wang C, Wu Z, Jiang H, et al. Elsevier BV. Journal of Global Antimicrobial Resistance. 2022;
Download PDF
Publication

A Comparative Clinical trial on trophic ulcers of Leprosy: Ayurvedic management was promising!

Gaikwad S, Gaikwad P. Journal of Medical Science and Clinical Research. 2022; 10 (8) : 57-64.
Download PDF
Publication

In silico designing of a recombinant multi-epitope antigen for leprosy diagnosis

Lemes MR, Rodrigues TCV, Jaiswal AK, et al. Springer Science and Business Media LLC. Journal of Genetic Engineering and Biotechnology. 2022;
Download PDF
Publication

Lucio Phenomenon and APLA in Hansen\'s Disease: A Rare Phenomenon

Sharma J, Chakroborty S, Karan K, et al. Jaypee Brothers Medical Publishing. Bengal Physician Journal. 2022; 9 (2) : 44-47.
Download PDF
Publication

Desafios atuais para a erradicação hanseníase: do diagnóstico ao tratamento

Souza BDS, Sales ACS, Moita LA, et al. Research, Society and Development. Research, Society and Development. 2022; 11 (11) : e196111133495.
Download PDF
Publication

Caracterización clínico epidemiológica de la lepra en el municipio Guisa

Carrasco J, Aldana R, Rodríguez M, et al. Folia Dermatológica Cubana. Folia Dermatológica Cubana. 2021;
Download PDF
Publication

Análise da hanseníase na região nordeste do Brasil no período de 2017-2021

Oliveira GGD, Gama AKS, Maia GMU, et al. Research, Society and Development. Research, Society and Development. 2022; 11 (11) : e46111133150.
Download PDF
Publication

Perfil epidemiológico da Hanseníase na microrregião da planície litorânea do Piauí

Maximiano HRL, Fernandes FLDS, Araújo FCJLC, et al. South Florida Publishing LLC. Brazilian Journal of Development. 2022;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 230
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD